Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus

Annals of Clinical and Laboratory Science

Volumn 36, Issue 2, 2006, Pages 174-178

  Hsu, Wan Ting ^a   Tsai, Li Yu ^a   Lin, Shu Kai ^a   Hsiao, Jen Kuei ^a   Chen, Bai Hsiun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diabetes mellitus type 1; Free radicals; Lipoperoxides; Superoxide anion; Vitamins A and E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; FREE RADICAL; GLUCOSE; HEMOGLOBIN A1C; LIPID PEROXIDE; RETINOL; SUPEROXIDE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; ERYTHROCYTES; FEMALE; FREE RADICALS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OXIDATIVE STRESS; TIME FACTORS;

EID: 33646526062     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sies H. Oxidative Stress: Oxidants and Antioxidants. Academic Press, New York, 1991.
2. Halliwell B. Free radicals, antioxidants, and human disease: cause or consequence? Lancet 1994;344:721-724.
3. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein FEBS Lett 1988;236:406-410.
4. Wolf SP. Diabetes mellitus and free radicals. Br Med Bull 1993;49:642-652.
5. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994;124:19-30.
6. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lefèvre PJ. Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med 1991;8:540-542.
7. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Prager R, et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995;98:469-475.
8. Laaksonen DE, Atalay M, Niskanen L, Uiritupa M, Häninen O, Sen CK. Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care 1996;19:569-574.
9. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. J Biol Chem 1987;262:16969-16972.
10. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, et al. On the pathogenesis of IDDM. Diabetologia 1994;37:S82-89.
11. Rabinovitch A, Suarez-Pinzón W, Strynadka K, Lakey JRT, Rajotte RV. Human pancreatic islet-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endicrinol Metab 1996;81:3197-3204.
12. Yoon JW, Kim CJ, Pak CY, McArthur RG. Effects of environmental factor on the development of insulin-dependent diabetes mellitus. Clin Invest Med 1987;10:457-469.
13. Guzel S, Seven A. Comparison of oxidative stress indicators in plasma of recent-onset and long-term type 1 diabetic patients. J Toxicol Environment Health 2000;59:7-14.
14. Asayama K, Uchida N, Nakane T, Hayashibe S, Dobashi K, Ameniya N, et al. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993;15:597-602.
15. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994;43:1010-1014.
16. Romay S, Baluja I, Pascual C. Total free radical-trapping capacity of serum from diabetics. Clin Chem 1994;40:2116-2117.
17. Vantyghem MC, Balduyck M, Zerimech F, Martin A, Douillard C, Bans S. Oxidative markers in diabetic ketoacidosis. J Endocrinol Invest 2000;23:732-736.
18. Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2000;251:69-76.
19. Dominguez C, Guessinye M, Ruiz E, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescences. Diabetes Care 1998;21:1736-1746.
20. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Giuseppe E, et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997;46:1853-1858.
21. Tarik A, Dlhadd DG, Hill A, McLaren M, Newton RW, Greene SA, et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab Res Rev 1999;15:405-411.
22. Jain SK, McVie R. Effect of gylcemic control, race (white vs. black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994;43:306-309.
23. Lee SC, Tsai SM, Lin SK, Chen BH, Tsai LY. Stability of total ascorbic acid in DTT-preserved plasma stored at 4°C. J Food Drug Anal 2004;12:217-220.
24. Hansen LG, Warwick WJ. A fluorometric micro-method for serum vitamin A and E. Am J Clin Pathol 1969;51:538-541.
25. Tsai LY, Tsai SM, Hong NC. A study of blood antioxidant and lipoxide effects of anticoagulants and sex-variation. Kaohsiung J Med Sci 1991;7:550-555.
26. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
27. Serru V, Baudin B, Ziegler F, David JP, Cals MJ, Vaubourdolle M, et al. Quantification of reduced and oxidized glutathione in whole blood samples by capillary electrophoresis. Clin Chem 2001;47:1321-1324.
28. Ciriaco C, Angelo Z, Giovanni MP, Givanini M, Bruna T, Luca D. Ultrarapid capillary electrophoresis method for the determination of reduced and oxidized glutathione in red blood cells. Electrophoresis 2002;23:1716-1721.
29. Gaeta LM, Tozzi G, Pastore A, Federici G, Bertini E, Piemonte F. Determination of superoxide dismutase and glutathione peroxidase activities in blood of healthy pediatric subjects. Clin Chim Acta 2002;322:117-120.
30. Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993;21:41-50.
31. Berge JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978;12:302-310.
32. Jos J, Rybak M, Patin PH, Robert JJ, Boitard C, Thevenion R. Antioxidant enzymes in insulin-dependent diabetes in the child and adolescent. Diabetes Metab 1990;16:498-503.
33. Murakami K, Kondo T, Ohtsuka Y, Fujiwara Y, Shimada M, Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1989;38:753-758.
34. Cerellio A, Bortolotti N, Pirisi M, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 1997;20:1589-1593.
35. Osterode W, Holler C, Ulberth F. Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin dependent) diabetes mellitus. Diabetes Med 1996;13:1044-1050.
36. Armstrong AM, Chestnutt JE, Gorley MJ, Young MJ, Young IS. The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed non-insulin dependent diabetes. Free Radic Biol 1996;21:719-726.
37. Will JC, Byers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996;54:193-202.
38. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994;97:S5-13.
39. Ruiz C, Alegria A, Barbera R, Farre R, Lagada MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999;59:99-105.